.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J06B_Immunoglobulins.J06BD06_Regdanvimab.Regdanvimab

Information

name:Regdanvimab
ATC code:J06BD06
route:intravenous
n-compartments2

Regdanvimab is a recombinant human monoclonal antibody targeting the receptor binding domain of the SARS-CoV-2 spike protein. It is used for the treatment of mild-to-moderate COVID-19 in certain patients and has received emergency or conditional authorizations in several countries.

Pharmacokinetics

Pharmacokinetic parameters reported in adults with COVID-19 following a single intravenous infusion.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos